𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasma levels of activated protein C–protein C inhibitor complex in patients with hypercoagulable states

✍ Scribed by Rika Watanabe; Hideo Wada; Miho Sakakura; Yoshitaka Mori; Takahiro Nakasaki; Yoshinaga Okugawa; Esteban C. Gabazza; Tatsuya Hayashi; Junji Nishioka; Koji Suzuki; Hiroshi Shiku; Tsutomu Nobori

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
108 KB
Volume
65
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of activated protein c in liver tran
Use of activated protein c in liver transplantation patients with septic shock
✍ Laura Rinaldi; Marco Marietta; Mariano Alejandro Mignini; Lara Donno; Stefano Bu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Recombinant human activated protein C (rhAPC) has been approved for use in patients with severe sepsis at high risk of death. Because of the high risk of bleeding, liver transplantation (LT) patients have been excluded from the randomized control trials that evaluated efficacy and safety of rhAPC an

Increased plasma levels of tissue factor
Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation
✍ Yoshinaga Okugawa; Hideo Wada; Tomohiro Noda; Miho Sakakura; Takahiro Nakasaki; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

Plasma levels of tissue factor pathway inhibitor (TFPI)-activated factor Xa (FXa) complex were measured in patients with disseminated intravascular coagulation (DIC), pre-DIC, and DIC. Plasma levels of plasmin-plasmin inhibitor complex (PPIC), D-dimer, and soluble fibrin monomer (SFM) were significa

Serum levels of hepatitis C virus core p
Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa
✍ E Tanaka; K Kiyosawa; A Matsumoto; T Kashiwakuma; A Hasegawa; H Mori; O Yanagiha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa